| Issue | Title | |
| Vol 17 (2010): Optimal management of metastatic colorectal cancer with the anti-EGFR monoclonal antibodies | Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer | Abstract PDF |
| M. Fakih, M. Vincent | ||
| Vol 25, No 5 (2018) | Afatinib in advanced pretreated non-small-cell lung cancer— a Canadian experience | Abstract PDF HTML |
| D. A. Ezeife, B. Melosky, R. Tudor, S. Lin, A. Lau, T. Panzarella, N. B. Leighl | ||
| Vol 21, No 1 (2014) | Age at diagnosis predicts local recurrence in women treated with breast-conserving surgery and postoperative radiation therapy for ductal carcinoma in situ: a population-based outcomes analysis | Abstract PDF HTML |
| I. Kong, S.A. Narod, C. Taylor, L. Paszat, R. Saskin, S. Nofech-Moses, D. Thiruchelvam, W. Hanna, J.P. Pignol, S. Sengupta, L. Elavathil, P.A. Jani, S.J. Done, S. Metcalfe, E. Rakovitch | ||
| Vol 25, No 1 (2018) | Alberta CancerBridges development of a care plan evaluation measure | Abstract PDF HTML |
| J. Giese-Davis, J. Sisler, L. Zhong, Y. Brandelli, J.L. McCormick, C. Railton, L. Shirt, H. Lau, D. Hao, J. Chobanuk, B. Walley, A.A. Joy, A. Taylor, L. Carlson | ||
| Vol 14, No 3 (2007) | Alemtuzumab in Chronic Lymphocytic Leukemia: A Systematic Review and Clinical Practice Guideline | Details PDF |
| Christopher A Smith | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | Algorithm for the treatment of advanced or metastatic squamous non-small-cell lung cancer: an evidence-based overview | Abstract PDF HTML |
| N. Daaboul, G. Nicholas, S. A. Laurie | ||
| Vol 20, No 1 (2013) | Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario | Abstract PDF HTML |
| R. Ramjeesingh, R.M. Meyer, M. Brouwers, B.E. Chen, C.M. Booth | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | ALK inhibitors, resistance development, clinical trials | Abstract PDF HTML |
| J.M. Rothenstein, N. Chooback | ||
| Vol 20, No 4 (2013) | Aloe vera for prevention of radiation-induced dermatitis: a self-controlled clinical trial | Abstract PDF HTML |
| P. Haddad, F. Amouzgar-Hashemi, S. Samsami, S. Chinichian, M.A. Oghabian | ||
| Vol 19, No 2 (2012) | Alternative and orthodox medicine and the “odd” principle | Abstract PDF HTML |
| L.Z.G. Touyz | ||
| Vol 18, No 2 (2011) | An appraisal of life’s terminal phases and euthanasia and the right to die | Details PDF HTML |
| L. Z.G. Touyz, S. J.J. Touyz | ||
| Vol 15, No 2 (2008) | An Approach to the Management of Chronic Myeloid Leukemia in British Columbia | Details PDF |
| Donna Lynn Forrest, X Jiang, C Eaves, C Smith | ||
| Vol 24, No 6 (2017) | An evaluation of the behaviour-change techniques used on Canadian cancer centre Web sites to support physical activity behaviour for breast cancer survivors | Abstract PDF HTML |
| B.D. Sylvester, K. Zammit, A.J. Fong, C.M. Sabiston | ||
| Vol 22, No 3 (2015) | An exploratory comparative analysis of tyrosine kinase inhibitors or docetaxel in second-line treatment of EGFR wild-type non-small-cell lung cancer: a retrospective real-world practice review at a single tertiary care centre | Abstract PDF HTML |
| K. Ma, V. Cohen, G. Kasymjanova, D. Small, K. Novac, J. Peterson, A. Levitt, J. Agulnik | ||
| Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective | AN INTEGRATED SUPPORT AND INFORMATION CENTRE IN A LARGE UK CANCER CENTRE ESTABLISHED IN 1993 & REPLICATED IN MORE THAN 60 UNITS ACROSS THE UK AND AUSTRALIA. | Abstract PDF |
| Jane Maher | ||
| Vol 22, No 3 (2015) | An intermediate step for the management of hypersensitivity to platinum and taxane chemotherapy | Abstract PDF HTML |
| M. Bahl, T. Dean | ||
| Vol 20, No 6 (2013) | An interprofessional palliative care oncology rehabilitation program: effects on function and predictors of program completion | Abstract PDF HTML |
| M.R. Chasen, A. Feldstain, D. Gravelle, N. MacDonald, J. Pereira | ||
| Vol 22, No 4 (2015) | An open-label expanded-access trial of bendamustine in patients with rituximab-refractory indolent non-Hodgkin lymphoma or previously untreated chronic lymphocytic leukemia: BEND-ACT | Abstract PDF HTML |
| C.T. Kouroukis, M. Crump, D. MacDonald, J.F. Larouche, D.A. Stewart, J. Johnston, S. Sauvageau, E. Beausoleil, P. Sage, S.G. Dubois, A. Christofides, S. Di Clemente, L. Sehn | ||
| Vol 16 (2009): Endocrine Therapy Update Supplement | An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor–positive early breast cancer | Abstract PDF |
| S. Verma, S. Sehdev, A Joy, Y. Madarnas, J. Younus, J. A. Roy | ||
| Vol 15, No 5 (2008) | Anal Cancer and Human Papillomaviruses in Heterosexual Men | Abstract PDF |
| Alan Nyitray | ||
| Vol 20, No 2 (2013) | Analysis of intraprostatic therapeutic effects in prostate cancer patients using [11C]-choline PET/CT after external-beam radiation therapy | Abstract PDF HTML |
| J. Amanie, H.S. Jans, M. Wuest, N. Pervez, A. Murtha, N. Usmani, D. Yee, R. Pearcey, B. Danielson, S. Patel, R. Macewan, C. Field, D. Robinson, J. Wilson, D. Lewis, M. Parliament, A.J.B. McEwan | ||
| Vol 22, No 6 (2015) | Analysis of liver-directed therapies in U.S. cancer patients | Abstract PDF HTML |
| O.B. Alese, S. Kim, Z. Chen, S.S. Ramalingam, T.K. Owonikoko, B.F. El-Rayes | ||
| Vol 22, No 2 (2015) | Analysis of sebum lipid composition and the development of acneiform rash before and after administration of egfr inhibitor | Abstract PDF HTML |
| T. Nakahara, Y. Moroi, K. Takayama, Y. Nakanishi, M. Furue | ||
| Vol 25, No 3 (2018) | Anastomosing hemangioma of the kidney: radiologic and pathologic distinctions of a kidney cancer mimic | Abstract PDF HTML |
| P.M. Cheon, R. Rebello, A. Naqvi, S. Popovic, M. Bonert, A. Kapoor | ||
| Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective | Androgen deprivation therapy for prostate cancer—review of indications in 2010 | Abstract PDF |
| H. Quon, D.A. Loblaw | ||
| Vol 19 (2012): Improving Patient Outcomes in Advanced Prostate Cancer | Androgen deprivation therapy in advanced prostate cancer: is intermittent therapy the new standard of care? | Abstract PDF HTML |
| L. Klotz, P. Toren | ||
| Vol 14, No 6 (2007) | Anemia is a common but neglected complication of adjuvant chemotherapy for early-stage breast cancer | Details PDF |
| Amanda Goldrick, Ivo A Olivotto, Cheryl Alexander, Caroline H Speers, Jeff Barnett, Sharon J Allan, Pauline T Truong | ||
| Vol 23, No 6 (2016) | Annual surveillance mammography after early-stage breast cancer and breast cancer mortality | Abstract PDF HTML |
| L.E. Paszat, R. Sutradhar, S. Gu, E. Rakovitch | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | Antiangiogenic therapies in non-small-cell lung cancer | Abstract PDF HTML |
| A. Alshangiti, G. Chandhoke, P.M. Ellis | ||
| Vol 21, No 1 (2014) | Anticancer activity of combination targeted therapy using cetuximab plus vemurafenib for refractory BRAFV600E-mutant metastatic colorectal carcinoma | Abstract PDF HTML |
| K. Connolly, D. Brungs, E. Szeto, R.J. Epstein | ||
| Vol 23 (2016): Use of Cannabinoids in Cancer Care | Anticancer mechanisms of cannabinoids | Abstract PDF HTML |
| G. Velasco, C. Sánchez, M. Guzmán | ||
| Vol 25, No 6 (2018) | Anti-Yo antibody–mediated paraneoplastic cerebellar degeneration associated with cognitive affective syndrome in a patient with breast cancer: a case report and literature review | Abstract PDF HTML |
| M. Le May, S. Dent | ||
| Vol 17, No 4 (2010) | Aplastic anemia with concurrent temozolomide treatment in a patient with glioblastoma multiforme | Abstract PDF |
| J. Oh, G.J. Kutas, P. Davey, M. Morrison, J.R. Perry | ||
| Vol 17, No 1 (2010) | Application of machine learning methodology for PET-based definition of lung cancer | Abstract PDF |
| A. Kerhet, C. Small, H. Quon, T. Riauka, L. Schrader, R. Greiner, D. Yee, A. McEwan, W. Roa | ||
| Vol 23, No 3 (2016) | Approach to biomarker testing: perspectives from various specialties | Abstract PDF HTML |
| M.R. Sung, P.M. Ellis, S. Verma, E. Duncan, N.B. Leighl | ||
| Vol 23, No 4 (2016) | Approach to fever assessment in ambulatory cancer patients receiving chemotherapy: a clinical practice guideline | Abstract PDF HTML |
| M.K. Krzyzanowska, C. Walker-Dilks, C. Atzema, A. Morris, R. Gupta, R. Halligan, T. Kouroukis, K. McCann | ||
| Vol 25, No 6 (2018) | Appropriate treatment receipt after breast-conserving surgery | Abstract PDF Supplemental Material HTML |
| K. Guidolin, M. Lock, K. Vogt, J. A. McClure, J. Winick-Ng, C. Vinden, M. Brackstone | ||
| Vol 21, No 6 (2014) | Aprepitant and granisetron for the prophylaxis of radiotherapy-induced nausea and vomiting after moderately emetogenic radiotherapy for bone metastases: a prospective pilot study | Abstract PDF HTML |
| K. Dennis, C. De Angelis, F. Jon, N. Lauzon, M. Pasetka, L. Holden, E. Barnes, C. Danjoux, A. Sahgal, M. Tsao, E. Chow | ||
| Vol 19, No 5 (2012) | Are bilateral cancers hereditary? Part II | Details PDF HTML |
| S. Narod | ||
| Vol 25, No 4 (2018) | Are clinical trial eligibility criteria an accurate reflection of a real-world population of advanced non-small-cell lung cancer patients? | Abstract PDF HTML |
| K. Al-Baimani, H. Jonker, T. Zhang, G.D. Goss, S.A. Laurie, G. Nicholas, P. Wheatley-Price | ||
| Vol 15, No 4 (2008) | Are Matrix Metalloproteinases Relevant Therapeutic Targets for Prostate Cancer Bone Metastasis? | Abstract PDF |
| R. Daniel Bonfil, Rafael Fridman, Shahriar Mobashery, Michael L. Cher | ||
| Vol 25, No 5 (2018) | Are patient-reported outcomes of physical function a valid substitute for objective measurements? | Abstract PDF HTML |
| J. A.J. Douma, H. M.W. Verheul, L. M. Buffart | ||
| Vol 22, No 5 (2015) | Are patients receiving the right care in the right place at the right time? | Abstract PDF HTML |
| M. Chasen, N. Dosani | ||
| Vol 20, No 4 (2013) | Are two-centimeter breast cancers large or small? | Abstract PDF HTML |
| S.A. Narod, J. Iqbal, A. Jakubowska, T. Huzarski, P. Sun, C. Cybulski, J. Gronwald, T. Byrski, J. Lubinski | ||
| Vol 25, No 2 (2018) | Aromatase inhibitors in premenopausal women with breast cancer: the state of the art and future prospects | Abstract PDF HTML |
| M. Pistelli, A. Della Mora, Z. Ballatore, R. Berardi | ||
| Vol 18, No 5 (2011) | Array comparative genomic hybridization and cytogenetic analysis in pediatric acute leukemias | Abstract PDF HTML |
| A. J. Dawson, R. Yanofsky, R. Vallente, S. Bal, I. Schroedter, L. Liang, S. Mai | ||
| Vol 17, No 6 (2010) | Arterial embolization for ruptured adrenal pheochromocytoma | Abstract PDF |
| M. Habib, I. Tarazi, M. Batta | ||
| Vol 17, No 6 (2010) | Arterial occlusion precipitated by cisplatin-based chemotherapy | Abstract PDF |
| D. Joseph, B. Dubashi, B. Karthikeyan, A. Jain | ||
| Vol 24, No 4 (2017) | ASCO 2017 meeting summary: updates to practice-changing studies in untreated non-Hodgkin lymphoma | Abstract PDF HTML |
| P. Laneuville, J.F. Larouche, A. Tosikyan, A. Christofides | ||
| Vol 20, No 2 (2013) | Assessing fitness to drive in brain tumour patients: a grey matter of law, ethics, and medicine | Abstract PDF HTML |
| A.V. Louie, E. Chan, M. Hanna, G.S. Bauman, B.J. Fisher, D.A. Palma, G.B. Rodrigues, A. Warner, D.P. D'Souza | ||
| Vol 25, No 1 (2018) | Assessing post-radiotherapy handover notes from a family physician perspective | Abstract PDF HTML Supplemental Materials |
| A. Dang, S. Miller, D. Horvat, T. Klassen-Ross, M. Graveline, R. Collins, R. Olson | ||
| Vol 18, No 6 (2011) | Assessment and management of febrile neutropenia in emergency departments within a regional health authority—a benchmark analysis | Abstract PDF HTML |
| D. Szwajcer, P. Czaykowski, D. Turner | ||
| Vol 19, No 3 (2012) | Assisted death and the slippery slope—finding clarity amid advocacy, convergence, and complexity | Abstract PDF HTML |
| M.J. Shariff | ||
| Vol 23, No 5 (2016) | Association between basal-like phenotype and BRCA1/2 germline mutations in Korean breast cancer patients | Abstract PDF HTML |
| J. Jung, E. Kang, J.M. Gwak, A.N. Seo, S.Y. Park, A.S. Lee, H. Baek, S. Chae, E.K. Kim, S.W. Kim | ||
| Vol 17, No 5 (2010) | Association of lipid metabolism with ovarian cancer | Abstract PDF |
| M. Tania, M.A. Khan, Y. Song | ||
| Vol 23, No 3 (2016) | Astragalus-containing Traditional Chinese Medicine, with and without prescription based on syndrome differentiation, combined with chemotherapy for advanced non-small-cell lung cancer: a systemic review and meta-analysis | Abstract PDF HTML |
| S.F. Wang, Q. Wang, L.J. Jiao, Y.L. Huang, D. Garfield, J. Zhang, L. Xu | ||
| Vol 25, No 2 (2018) | Ataxia–telangiectasia gene (ATM) mutation heterozygosity in breast cancer: a narrative review | Abstract PDF HTML |
| K.J. Jerzak, T. Mancuso, A. Eisen | ||
| Vol 18, No 6 (2011) | Author Index | Abstract PDF HTML |
| Current Oncology | ||
| Vol 19, No 6 (2012) | Author Index | Details PDF HTML |
| Current Oncology | ||
| Vol 20, No 6 (2013) | Author Index | Details PDF HTML |
| Various Authors | ||
| Vol 21, No 6 (2014) | Author Index | Abstract PDF HTML |
| Various Authors | ||
| Vol 13, No 1 (2006) | Awareness and Use of the Rapid Palliative Radiotherapy Program by Family Physicians in Eastern Ontario: A Survey | Details PDF |
| E J Fitzgibbon | ||
| Vol 20, No 3 (2013) | Axillary lymph node status, adjusted for pathologic complete response in breast and axilla after neoadjuvant chemotherapy, predicts differential disease-free survival in breast cancer | Abstract PDF HTML |
| G.C. Zhang, Y.F. Zhang, F.P. Xu, X.K. Qian, Z.B. Guo, C.Y. Ren, M. Yao | ||
| Vol 25, No 1 (2018) | Azacitidine-induced pyoderma gangrenosum at injection sites in a patient with myelodysplastic syndrome | Abstract PDF HTML |
| C. Roy, J.P. Adam, F. Morin, É. Lemieux-Blanchard, S. Doucet, D. Friedmann, A. Belisle, D. Charpentier | ||
| Vol 17, No 3 (2010) | Balancing potential quality-of-life benefits against the risk of lethal late recurrence with bladder-preserving surgery | Abstract PDF |
| L. Klotz | ||
| Vol 25, No 2 (2018) | Barriers to participation in clinical trials: a physician survey | Abstract PDF HTML |
| A. Mahmud, O. Zalay, A. Springer, K. Arts, E. Eisenhauer | ||
| Vol 25, No 4 (2018) | Baseline Edmonton Symptom Assessment System and survival in metastatic renal cell carcinoma | Abstract PDF HTML |
| J. Graham, J. Gingerich, P. Lambert, A. Alamri, P. Czaykowski | ||
| Vol 20, No 5 (2013) | Benefits, issues, and recommendations for personalized medicine in oncology in Canada | Abstract PDF HTML |
| C. Butts, S. Kamel–Reid, G. Batist, S. Chia, C. Blanke, M. Moore, M.B. Sawyer, C.C. Desjardins, A. Dubois, J. Pun, K. Bonter, Fredrick D Ashbury | ||
| Vol 17, No 5 (2010) | Bevacizumab in combination with FOLFIRI chemotherapy in patients with metastatic colorectal cancer: an assessment of safety and efficacy in the province of Newfoundland and Labrador | Abstract PDF |
| G. Dranitsaris, S. Edwards, J. Edwards, M. Leblanc, R. Abbott | ||
| Vol 20, No 5 (2013) | Bevacizumab-based therapy for colorectal cancer: experience from a large Canadian cohort at the Jewish General Hospital between 2004 and 2009 | Abstract PDF HTML |
| N. Bouganim, A. Mamo, D.W. Wasserman, G. Batist, P. Metrakos, P. Chaudhury, M. Hassanain, P. Kavan | ||
| Vol 22, No 3 (2015) | Beyond the mammography debate: a moderate perspective | Abstract PDF HTML |
| C. Kaniklidis | ||
| Vol 21, No 1 (2014) | Bilineal T lymphoblastic and myeloid blast transformation in chronic myeloid leukemia with TP53 mutation—an uncommon presentation in adults | Abstract PDF HTML |
| S. Krishnan, K. Sabai, C. Chuah, S.Y. Tan | ||
| Vol 15, No 2 (2008) | Biochemotherapy for the Treatment of Metastatic Malignant Melanoma: A Clinical Practice Guideline | Abstract PDF |
| Denise Stys-Norman | ||
| Vol 23, No 5 (2016) | Bioelectrical impedance phase angle as a prognostic indicator of survival in head-and-neck cancer | Abstract PDF HTML |
| M.S. Wladysiuk, R. Mlak, K. Morshed, W. Surtel, A. Brzozowska, T. Małecka-Massalska | ||
| Vol 21, No 4 (2014) | Biologic, psychological, and social health needs in cancer care: how far have we come? | Abstract PDF HTML |
| F. Schulte | ||
| Vol 13, No 1 (2006) | Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma | Details PDF |
| Lara J Williams, Duane L Guernsey, Alan G Casson | ||
| Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective | Biomarkers that currently affect clinical practice: EGFR, ALK, MET, KRAS | Abstract PDF HTML |
| M.D. Vincent, M.S. Kuruvilla, N.B. Leighl, S. Kamel-Reid | ||
| Vol 16, No 6 (2009) | Bogarting that joint might decrease oral HPV among cannabis users | Abstract PDF |
| S. Zwenger | ||
| Vol 17 (2010): Managing Prostate Cancer in 2010 and Beyond: A Canadian Perspective | Bone health in nonmetastatic prostate cancer: what’s the big deal? | Abstract PDF |
| J.B. Lattouf, F. Saad | ||
| Vol 19, No 5 (2012) | Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art | Abstract PDF HTML |
| M. Clemons, K.A. Gelmon, K.I. Pritchard, A.H.G. Paterson | ||
| Vol 17, No 4 (2010) | BONUS 5: 5th Annual Bone and The Oncologist New Updates | Abstract PDF |
| N. Bouganim, E. Amir, M. Clemons | ||
| Vol 23, No 5 (2016) | Book review: Balanced Ethics Review: A Guide for Institutional Review Board Members | Abstract PDF HTML |
| T. Christie | ||
| Vol 23, No 1 (2016) | Book review: Hypnotic Approaches in Cancer and Palliative Care | Abstract PDF HTML |
| G. Giddings | ||
| Vol 22, No 3 (2015) | Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty | Abstract PDF HTML |
| C.I. Falkson | ||
| Vol 22, No 3 (2015) | Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty | Abstract PDF HTML |
| G. Giddings | ||
| Vol 22, No 3 (2015) | Book review: Therapeutic Revolution: The History of Medical Oncology From Early Days to the Creation of the Subspecialty | Abstract PDF HTML |
| J. Ragaz, S. Shakeraneh | ||
| Vol 13, No 5 (2006) | Bortezomib in Multiple Myeloma and Lymphoma: A systematic review and clinical practice guideline | Details PDF |
| Christopher A Smith | ||
| Vol 21, No 4 (2014) | Bortezomib in multiple myeloma: systematic review and clinical considerations | Abstract PDF HTML |
| T.C. Kouroukis, F.G. Baldassarre, A.E. Haynes, K. Imrie, D.E. Reece, M.C. Cheung | ||
| Vol 21, No 6 (2014) | BRAF mutation correlates with recurrent papillary thyroid carcinoma in Chinese patients | Abstract PDF HTML |
| W.Y. Fang, L. Ye, X.F. Zhang, L.Y. Shen, R.L. Han, Q. Wei, X.C. Fei, X. Chen, W.Q. Wang, S. Wang, G. Ning | ||
| Vol 16, No 1 (2009) | Brain Metastases from Unknown Primary or Primary Brain Tumor: A Diagnostic Dilemma | Details PDF |
| Sarah Campos, Philip Davey, Amanda Hird, Bryn Pressnail, Juan Bilbao, Richard Aviv, Sean Symons, Farhad Pirouzmand, Emily Sinclair, Shaelyn Culleton, Eric deSa, Philiz Goh, Edward Chow | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | Brain metastases in non-small-cell lung cancer: are tyrosine kinase inhibitors and checkpoint inhibitors now viable options? | Abstract PDF HTML |
| S. Morin-Ben Abdallah, A. Wong | ||
| Vol 22, No 4 (2015) | BRCA1/2 population screening: embracing the benefits | Abstract PDF HTML |
| S.E. Plon | ||
| Vol 18, No 1 (2011) | Breaking new ground in a new year | Details PDF HTML |
| M. McLean | ||
| Vol 21, No 5 (2014) | Breast and cervical cancer screening behaviours among colorectal cancer survivors in Nova Scotia | Abstract PDF HTML |
| M. Corkum, R. Urquhart, G. Kephart, J.A. Hayden, G. Porter | ||
| Vol 24, No 5 (2017) | Breast cancer and dermatomyositis: a case study and literature review | Abstract PDF HTML |
| E. Hendren, O. Vinik, H. Faragalla, R. Haq | ||
| Vol 20, No 1 (2013) | Breast cancer and the environment: what is left to learn? | Details PDF HTML |
| S. Narod | ||
| Vol 20, No 5 (2013) | Breast cancer and the environment: why research and preventive action are needed | Abstract PDF HTML |
| J.T. Brophy, M.M. Keith, R. Park, A. Watterson, M. Gilbertson, R. DeMatteo | ||
| Vol 22, No 5 (2015) | Breast cancer screening panels continue to confuse the facts and inject their own biases | Abstract PDF HTML |
| D.B. Kopans | ||
| Vol 20, No 2 (2013) | Breast cancer survivorship and South Asian Women: understanding about the follow-up care plan and perspectives and preferences for information post treatment | Abstract PDF HTML |
| S. Singh-Carlson, F. Wong, L. Martin, S.K.A. Nguyen | ||
| Vol 24, No 3 (2017) | Breast magnetic resonance imaging: are those who need it getting it? | Abstract PDF HTML |
| S. Tan, J. David, L. Lalonde, M. El Khoury, M. Labelle, R. Younan, E. Patocskai, J. Richard, I. Trop | ||
| 101 - 200 of 1530 Items | << < 1 2 3 4 5 6 7 8 9 10 > >> | |
User
Current Oncology is published by:
Endorsed publication of the Canadian Association of Psychosocial Oncology (CAPO)
